[go: up one dir, main page]

NO982727D0 - PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon - Google Patents

PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon

Info

Publication number
NO982727D0
NO982727D0 NO982727A NO982727A NO982727D0 NO 982727 D0 NO982727 D0 NO 982727D0 NO 982727 A NO982727 A NO 982727A NO 982727 A NO982727 A NO 982727A NO 982727 D0 NO982727 D0 NO 982727D0
Authority
NO
Norway
Prior art keywords
pge
treatment
erectile dysfunction
containing lyophilized
lyophilized liposomes
Prior art date
Application number
NO982727A
Other languages
English (en)
Other versions
NO982727L (no
Inventor
Jackie R See
Original Assignee
Harvard Scient Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard Scient Corp filed Critical Harvard Scient Corp
Publication of NO982727D0 publication Critical patent/NO982727D0/no
Publication of NO982727L publication Critical patent/NO982727L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO982727A 1995-12-15 1998-06-12 PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon NO982727L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/573,408 US5718917A (en) 1995-12-15 1995-12-15 PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
PCT/US1996/018820 WO1997022334A1 (en) 1995-12-15 1996-11-26 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction

Publications (2)

Publication Number Publication Date
NO982727D0 true NO982727D0 (no) 1998-06-12
NO982727L NO982727L (no) 1998-08-17

Family

ID=24291879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982727A NO982727L (no) 1995-12-15 1998-06-12 PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon

Country Status (17)

Country Link
US (1) US5718917A (no)
EP (1) EP0874622A4 (no)
JP (1) JPH11504945A (no)
KR (1) KR20000064392A (no)
CN (1) CN1207671A (no)
AU (1) AU722555B2 (no)
BR (1) BR9612040A (no)
EA (1) EA199800565A1 (no)
EE (1) EE9800182A (no)
HU (1) HUP9902094A2 (no)
IL (1) IL124841A (no)
IS (1) IS4767A (no)
NO (1) NO982727L (no)
PL (1) PL327400A1 (no)
SK (1) SK80998A3 (no)
TR (1) TR199801104T2 (no)
WO (1) WO1997022334A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
KR100195348B1 (ko) * 1996-10-31 1999-06-15 장용택 안정한 프로스타글란딘 e1-함유 주사제 조성물
JP2001509480A (ja) 1997-07-09 2001-07-24 アンドロソリューションズ，インク． 男性勃起機能不全を治療するための改良された方法及び組成物
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US20020004529A1 (en) * 1997-10-20 2002-01-10 Gary W. Neal Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US6046240A (en) * 1998-05-01 2000-04-04 Harvard Scientific Corporation Methods for treating female sexual dysfunction
KR100350179B1 (ko) * 1998-09-23 2002-08-27 구주제약주식회사 Ｓｅｄｄｓ로 제제화한 발기부전치료용 주입액제
WO2000051978A1 (en) * 1999-03-01 2000-09-08 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
CN1314444C (zh) * 2003-03-20 2007-05-09 蔡海德 一种治疗糠尿病及其并发症和病毒性肝炎的组合药物及其制备方法
JP2007522085A (ja) * 2003-06-27 2007-08-09 スミスクライン・ビーチャム・コーポレイション 安定化されたトポテカンリポソーム組成物および方法
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
CN101095944B (zh) * 2007-07-10 2012-04-18 上海市肿瘤研究所 一种预防和治疗前列腺炎穴位缓释贴片及其制品、制备方法和用途
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
CN102133182A (zh) * 2010-12-30 2011-07-27 北京中海康医药科技发展有限公司 一种依前列醇脂质体及其制备方法
US9962393B1 (en) * 2015-06-21 2018-05-08 Angiosoma Research, Inc. Method for treating vascular disease by administering a liposomal prostaglandin composition

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US246697A (en) * 1881-09-06 wadleigh
US251355A (en) * 1881-12-27 Edwin h
US3993754A (en) * 1974-10-09 1976-11-23 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome-encapsulated actinomycin for cancer chemotherapy
GB1536215A (en) * 1976-07-05 1978-12-20 Decca Ltd Clamping circuits for television signals
US4086257A (en) * 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4533254A (en) * 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
US5040453A (en) * 1982-07-12 1991-08-20 Turn Act Inc. Actuator housing continuation
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US4975282A (en) * 1985-06-26 1990-12-04 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures
US4955878A (en) * 1986-04-04 1990-09-11 Biotechnology, Inc. Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
US4749585A (en) * 1986-04-11 1988-06-07 University Of Medicine And Dentistry Of New Jersey Antibiotic bonded prosthesis and process for producing same
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
AU617678B2 (en) * 1987-05-22 1991-12-05 Liposome Company, Inc., The Prostaglandin-lipid formulations
US4776848A (en) * 1987-07-20 1988-10-11 Anthony Solazzo Urethral fluid application device and system
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US4880835A (en) * 1988-11-03 1989-11-14 Formulations Development Labs, Inc. Oral liquid pharmaceutical compositions of sulindac
JPH0395118A (ja) * 1989-09-07 1991-04-19 Green Cross Corp:The プロスタグランジン含有脂肪小体製剤
US5164320A (en) * 1990-03-05 1992-11-17 Becton, Dickinson And Company Method for lysing hard liposomes using polyethyleneglycol mono-n-alkyl ethers
IT1252603B (it) * 1990-04-19 1995-06-19 Giorgio Cavallini 2,4-diamino-6 piperidino pirimidina-3 ossido topico sul glande nel trattamento delle impotenze erettili
EP0526566B1 (en) * 1990-04-25 1998-11-25 Vivus, Inc. Treatment of erectile dysfunction
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
EP0484581B1 (de) * 1990-11-08 1994-06-15 Roche Diagnostics GmbH Verwendung von Thromboxan-A2-Antagonisten zur Verhinderung von degenerativen Vorgängen im penilen Gewebe
US5399581A (en) * 1990-12-26 1995-03-21 Laragh; John H. Method and compositions for treatment of sexual impotence
DK0512916T3 (da) * 1991-05-07 1999-09-20 Liposome Co Inc Liposomale prostaglandinformuleringer
JPH05139977A (ja) * 1991-05-17 1993-06-08 Green Cross Corp:The プロスタグランジン類リポソーム複合体を充填した注射器
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
WO1993000894A1 (en) * 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
US5422371A (en) * 1992-05-27 1995-06-06 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5370613A (en) * 1993-02-11 1994-12-06 Helmy; Ali M. Catheter apparatus for delivering drugs to the penis
ATE195866T1 (de) * 1993-07-28 2000-09-15 Pharmaderm Lab Ltd Zweiphasige multilamellare lipidvesikel
US5419763B1 (en) * 1994-01-04 1997-07-15 Cor Trak Medical Inc Prostatic drug-delivery catheter
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
CN1101192C (zh) * 1994-08-05 2003-02-12 英法马有限公司 用于局部治疗阳痿的组合物
GB9423910D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
EP0874622A1 (en) 1998-11-04
IS4767A (is) 1998-06-09
PL327400A1 (en) 1998-12-07
EE9800182A (et) 1998-12-15
WO1997022334A1 (en) 1997-06-26
CN1207671A (zh) 1999-02-10
EP0874622A4 (en) 1999-02-10
US5718917A (en) 1998-02-17
AU1024297A (en) 1997-07-14
KR20000064392A (ko) 2000-11-06
IL124841A (en) 2001-01-28
SK80998A3 (en) 1999-01-11
EA199800565A1 (ru) 1999-02-25
JPH11504945A (ja) 1999-05-11
IL124841A0 (en) 1999-01-26
AU722555B2 (en) 2000-08-03
HUP9902094A2 (hu) 1999-10-28
TR199801104T2 (xx) 1998-10-21
NO982727L (no) 1998-08-17
BR9612040A (pt) 1999-12-28

Similar Documents

Publication Publication Date Title
FI972205A0 (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
CY2006007I2 (el) Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας
GB9608408D0 (en) Treatment of erectile dysfunction
EE03512B1 (et) Epinastiin kasutamiseks valude ravis
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
ID17156A (id) Zat-zat anti koagulan yang berguna dalam pengobatan trombosis
ZA963287B (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
NO982727D0 (no) PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon
FI953838L (fi) Imidatsopyriidineja ja niiden käyttö maha-suolisairauksien hoidossa
FI963252L (fi) Kivun hoitoon tarkoitetut uudet opioidipeptidit ja niiden käyttö
ID16981A (id) Konsentrat-konsentrat mutiara yang encer
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
EP1079764A4 (en) TREATMENT OF SEXUALITY DISORDERS IN CERTAIN GROUPS OF PATIENTS
ZA984177B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
BR9709636A (pt) Uso de buckminsterfulereno no tratamento de ferimento neurotóxico
NO983402L (no) Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner
NO20022101D0 (no) Peptider for behandling av erektil dysfunksjon
BR9702075A (pt) Derivados de uréida biologicamente ativos úteis no tratamento de esclerose múltipla
GB9612990D0 (en) Compositions and methods for the treatment of chronic infections
NO942963D0 (no) Behandling av erektil dysfunksjon
GB9603657D0 (en) Improvements in the treatment of vaginal infections
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
KR960033565U (ko) 지압 및 쑥뜸 겸용 지압구